We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cenkos Securities Plc | LSE:CNKS | London | Ordinary Share | GB00B1FLHR07 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/2/2017 08:35 | I got a flyer yesterday advertising their deals in January so far. Growth companies team already raised £75m for three deals. Very strong start. That's about £3-4m fees. | markie7 | |
03/2/2017 08:26 | Cheers spob, thanks. | cwa1 | |
03/2/2017 08:07 | blvn bvc avg char cros mmc tbgr hat mnl cnks | spob | |
03/2/2017 07:36 | Morning speeds That article is locked to subscribers only(for good reason). May I ask if you could, subtly, give us a flavour of the other stocks mentioned in the portfolio? Just so as I know what to sell you understand ;-) | cwa1 | |
02/2/2017 23:14 | Not convinced that this is necessarily a positive but Cenkos have been included in Simon Thompson's 2017 Bargain Shares Portfolio in Investors Chronicle. He admits that 2016 was an 'annus horribilis' for the company but believes that at the current level the risk/reward looks tilted to the upside. Also points out that Cenkos has been profitable every year since it was founded, has a strong debt-free balance sheet with management having significant skin in the game. 2016 numbers are likely to look awful but the market should be forward looking with a better outlook for the current year. Bargain Shares Portfolio 2017 - No new info in there, all points that have been raised by various people in the past but he basically reckons Cenkos look good value at the current share price. Now, if that isn't the kiss of death, I don't know what is ;-) | speedsgh | |
01/2/2017 09:43 | Good spot. Plenty of small cap activity going on like this with cenkos decently placed to benefit. Clear buy I'd say | markie7 | |
01/2/2017 09:34 | Cenkos acting on £15m placing for Cello Group (CLL)... Placing & Acquisition of Defined Health - The Placing will raise gross proceeds of £15.0 million (net proceeds of approximately £14.1 million) for the Company. The Placing price of £0.97 per Placing Share represents a premium of 0.5 per cent. to the closing mid-market price on 31 January 2017... ...The Placing Shares have been conditionally placed by Cenkos, as agent for the Company. | speedsgh | |
25/1/2017 08:33 | Cenkos acting for Kromek (KMK) on £21m placing/open offer... Firm Placing and Open Offer to raise up to £21m - | speedsgh | |
24/1/2017 10:32 | oops. sorry | qackers | |
24/1/2017 10:06 | Or possibly even the same "new business" reported on 16/1 in case anyone gets in the least bit excited about it :-) | cwa1 | |
24/1/2017 09:38 | More new business. RNS Number : 1916U BowLeven Plc 16 January 2017 Bowleven plc ('Bowleven' or 'the Company') Change of Adviser Bowleven is pleased to announce the appointment of Cenkos Securities plc ("Cenkos") as the Company's Nominated Adviser (NOMAD) and Joint Broker with immediate effect. Barclays will remain Joint Broker to the Company alongside Cenkos. | qackers | |
18/1/2017 14:37 | ... when Cenkos under-performs with £1 Billion raised and Zeus gets excited with the same amount .... | keith95 | |
18/1/2017 14:03 | Nevermind Zeus the buyers are back buying CNKS today. | garycook | |
18/1/2017 13:23 | Seems like one of Cenkos's major competitors, Zeus Capital, have been pretty busy in 2016. Up to each to decide whether Zeus has been outperforming or Cenkos underperforming or neither of the above. Deals top £1bn at investment bank Zeus Capital - | speedsgh | |
16/1/2017 09:40 | CNKS looking "great value" with "big IPOs coming back", tweets Paul Scott | zho | |
16/1/2017 07:31 | Another one for the Portfolio.Every little helps.Coming back strong now from 69p.It looks like there is a gap fill to be met at 115p | garycook | |
16/1/2017 07:24 | Bowleven is pleased to announce the appointment of Cenkos Securities plc ("Cenkos") as the Company's Nominated Adviser (NOMAD) and Joint Broker with immediate effect. Barclays will remain Joint Broker to the Company alongside Cenkos. | cwa1 | |
13/1/2017 16:13 | Impressive strength here. There were c. 43,000 of sales in the hour or so after midday and the price didn't budge: I thought there must have been a chunky delayed buy to soak up those sales, but apparently not. | zho | |
13/1/2017 15:14 | On 28 April 2016 Cenkos announced that the trustees of the Cenkos EBT had launched a share purchase plan to buy up to £50,000 of Cenkos shares a month. 102,000 shares were purchased in H1 2016 under this plan at a cost of £142,571. The increase in the size of the Company’s EBT reflects, in part, the potential future demand for Cenkos’ shares to satisfy share awards under the Company’s 2015 deferred bonus scheme. If the boo boy numpties understood time series they would have noticed that CNKS HAS had a tendency to rally in the first part of every month thus far :) There just isn't the volume to keep selling on the hope of spooking retail investors with such a big buyer in the background. | keith95 | |
12/1/2017 19:05 | QuePassa12 Jan '17 - 06:35 - 2124 of 2124 0 0 (Filtered) Correction - Boo Boys :) | keith95 | |
12/1/2017 06:35 | if you are referring to me.....how very wrong you are but thanks for reminding me to use the voting buttons. QP | quepassa | |
11/1/2017 23:53 | See the resident boo boy is down voting .... | keith95 | |
11/1/2017 19:02 | Guess this general share price rise with indices at highs is very good for delivering their pipeline. A tad too early for December financials to be finalised at the moment though! | topvest |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions